These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 7649915)

  • 21. Characterization of antioxidant activities of pulmonary surfactant mixtures.
    Matalon S; Holm BA; Baker RR; Whitfield MK; Freeman BA
    Biochim Biophys Acta; 1990 Aug; 1035(2):121-7. PubMed ID: 2393661
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exogenous surfactant decreases oxygenation in Escherichia coli endotoxin-treated neonatal piglets.
    Sood SL; Balaraman V; Finn KC; Wilkerson SY; Mundie TG; Easa D
    Pediatr Pulmonol; 1996 Dec; 22(6):376-86. PubMed ID: 9016471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Exogenous surfactants in a piglet model of acute respiratory distress syndrome.
    Sood SL; Balaraman V; Finn KC; Britton B; Uyehara CF; Easa D
    Am J Respir Crit Care Med; 1996 Feb; 153(2):820-8. PubMed ID: 8564138
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative efficacy of exosurf and survanta surfactants on early clinical course of respiratory distress syndrome and complications of prematurity.
    Modanlou HD; Beharry K; Padilla G; Norris K; Safvati S; Aranda JV
    J Perinatol; 1997; 17(6):455-60. PubMed ID: 9447532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosurf treatment following wood smoke inhalation.
    Feldbaum DM; Wormuth D; Nieman GF; Paskanik M; Clark WR; Hakim TS
    Burns; 1993 Oct; 19(5):396-400. PubMed ID: 8216766
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Surfactant downregulates synthesis of DNA and inflammatory mediators in normal human lung fibroblasts.
    Thomassen MJ; Antal JM; Barna BP; Divis LT; Meeker DP; Wiedemann HP
    Am J Physiol; 1996 Jan; 270(1 Pt 1):L159-63. PubMed ID: 8772539
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of human alveolar macrophage inflammatory cytokines by tyloxapol: a component of the synthetic surfactant Exosurf.
    Thomassen MJ; Antal JM; Divis LT; Wiedemann HP
    Clin Immunol Immunopathol; 1995 Nov; 77(2):201-5. PubMed ID: 7586728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lung function in prematurely delivered rabbits treated with a synthetic surfactant.
    Tooley WH; Clements JA; Muramatsu K; Brown CL; Schlueter MA
    Am Rev Respir Dis; 1987 Sep; 136(3):651-6. PubMed ID: 3307569
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quantitation of the alveolar distribution of surfactant mixtures in normal and injured lungs.
    Pataki G; Czopf L; Holm BA; Matalon S
    Am J Respir Cell Mol Biol; 1996 Oct; 15(4):451-9. PubMed ID: 8879178
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Surface tension of therapeutic surfactants (exosurf neonatal, infasurf, and survanta) as evaluated by standard methods and criteria.
    Scarpelli EM; David E; Cordova M; Mautone AJ
    Am J Perinatol; 1992; 9(5-6):414-9. PubMed ID: 1418146
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Alveolar metabolism of natural vs. synthetic surfactants in preterm newborn rabbits.
    Allen V; Oulton M; Stinson D; MacDonald J; Allen A
    J Appl Physiol (1985); 2001 Jan; 90(1):198-204. PubMed ID: 11133911
    [TBL] [Abstract][Full Text] [Related]  

  • 32. In vitro inactivation of pulmonary surfactant replacement preparations by serum albumin.
    Bummer PM; Sanders LP; Pauly TH; Gillespie MN
    Am J Med Sci; 1994 Jun; 307(6):401-4. PubMed ID: 8198144
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibitory effects of oxyradicals on surfactant function: utilizing in vitro Fenton reaction.
    Amirkhanian JD; Merritt TA
    Lung; 1998; 176(1):63-72. PubMed ID: 9436178
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The physiologic effects of surfactant treatment on gas exchange in newborn premature infants with hyaline membrane disease.
    Cotton RB; Olsson T; Law AB; Parker RA; Lindstrom DP; Silberberg AR; Sundell HW; Sandberg K
    Pediatr Res; 1993 Oct; 34(4):495-501. PubMed ID: 8255684
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surfactant inhibits cationic liposome-mediated gene transfer.
    Tsan MF; Tsan GL; White JE
    Hum Gene Ther; 1997 May; 8(7):817-25. PubMed ID: 9143907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biochemical reactivity of melatonin with reactive oxygen and nitrogen species: a review of the evidence.
    Reiter RJ; Tan DX; Manchester LC; Qi W
    Cell Biochem Biophys; 2001; 34(2):237-56. PubMed ID: 11898866
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of different surfactant preparations on bacterial growth in vitro.
    Neumeister B; Woerndle S; Bartmann P
    Biol Neonate; 1996; 70(2):128-34. PubMed ID: 8864432
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of three surfactant preparations on in vitro lymphocyte functions.
    Woerndle S; Bartmann P
    J Perinat Med; 1994; 22(2):119-28. PubMed ID: 7965541
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of intra-amniotic administration of Exosurf in preterm rabbit fetuses.
    Galan HL; Kuehl TJ
    Obstet Gynecol; 1992 Oct; 80(4):604-8. PubMed ID: 1407880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunosuppressive properties of surfactant and plasma on alveolar macrophages.
    Allen JN; Moore SA; Pope-Harman AL; Marsh CB; Wewers MD
    J Lab Clin Med; 1995 Mar; 125(3):356-69. PubMed ID: 7897303
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.